Athens, 06.29.2020 – GENESIS Pharma won the Platinum Award for its CSR performance for 2019-2020 in the Greek Corporate Responsibility Index (CR Index) by the Corporate Responsibility Institute. The company also received the "Best Progress Award" demonstrating the greater progress in its category, as an acknowledgment of its growing investment and improving performance in sustainable practices and social contribution activities.
During the CR Index process, independent experts evaluate the CSR performance of the participating companies and their impact on society, the environment, the market and the workplace, based on international standards and criteria. GENESIS Pharma is among the most awarded companies in Greece for its CSR performance, as it was the first pharmaceutical company to participate and be awarded in the index since 2009.
Partnership with GENESIS Pharma marks an important step in the global commercial expansion of patisiran, the first-in-class ‘gene-silencing’ RNAi therapeutic
Under the terms of the agreement, GENESIS Pharma will be responsible for the sales and marketing, medical affairs, regulatory and reimbursement support for migalastat in the above markets.
The company supports her Olympic preparations for the 10km Open Water Finals of the Rio Olympics.
Since 2014, GENESIS Pharma has been supporting the efforts of the Greek marathon swimmer Kelly Araouzou for qualification to the Rio Olympics 2016 as an exclusive sponsor, while today it stands by her in the final stretch before the big finals of the 10km open water swimming to be held on August 15, 2016.
Kelly earned her qualification for the Olympics a year ago, at the 16th FINA World Championships in Kazan where she won the 8th place in the 10km open water swimming. In Kazan she also won a silver medal in the 5km open water swimming, her highest personal achievement to date.
For the third consecutive year, GENESIS Pharma received a gold award for its overall performance in corporate responsibility while this year the company was honored with a special distinction for its social contribution in the Greek Corporate Responsibility Index.The company was also awarded by the Greek Institute for Corporate Responsibility for its commitment to corporate responsibility and its long-term presence in the Greek Corporate Responsibility Index, becoming one out of the three companies in Greece to receive such a distinction.
For the sixth consecutive year GENESIS Pharma is awarded in the National Corporate Responsibility Index-CR Index, receiving its second Gold award. This long-term presence in the Index as well as the improved scores that the company has achieved over the years signify its strong commitment to corporate responsibility.
The Greek pharmaceutical company GENESIS Pharma ranked among the top 110 European companies in the European Business Awards 2014-15 sponsored by RSM, receiving the “Ruban d’ Honneur” honorary title and the ticket to the finals.